Keyword: United Kingdom

NICE said it's "actively engaging" with Biogen to address "uncertainties" about Spinraza's long-term effectiveness.

Activists have railed at the U.K. government for refusing to offer Merck's HPV vaccine Gardasil to boys, but now the government has reversed its stance.

With Brexit looming, AstraZeneca has taken up three lines of defense to forestall potential supply disruptions.

Vertex CEO Jeffrey Leiden took his fight over CF drug prices to U.K. Prime Minister Theresa May, urging her to step in.

As the public plots protests, officials plan a black-tie dinner with the president and PM Theresa May—and J&J, GSK chiefs are invited.

Sanofi offered a confidential discount as part of a process to secure coverage for Dupixent in the U.K.

Patients in the U.K. won't have access to X-linked hypophosphatemia med Crysvita under a ruling by NICE.

After U.K. antitrust authorities smacked Pfizer with a record fine over a 2,600% price hike, the drugmaker won an appeal.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.